Additional information
White Powder
120512-03-0
ACI-014623
137.4-139.8°C
C17H21N5O
311.38
Ambient
2-8°C
Antiestrogen
Pharmaceutical Impurity Standards
3-(1-Cyano-1-methylethyl)-a,a-dimethyl-5-(1H-1,2,4-triazol-1-ylmethyl)benzeneacetamide(Anastrozole monoamide mononitrile impurity)
3-(1-Cyano-1-methylethyl)-a,a-dimethyl-5-(1H-1,2,4-triazol-1-ylmethyl)benzeneacetamide(Anastrozole monoamide mononitrile impurity)
2-(3-((1H-1,2,4-Triazol-1-yl)methyl)-5-(2-cyanopropan-2-yl)phenyl)-2-methylpropanamide





![BUTOXYQUINOLINONE BREXPIPRAZOLE (25 mg) (7-[4-(7-{4-[4-(Benzo[b]thiophen-4-yl)piperazin-1-yl]butoxy}quinolin-2-yloxy)butoxy]quinolin-2(1H)-one)](https://analyticachemie.in/wp-content/uploads/uspimage-1.jpg)